Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125620411 | 12562041 | 1 | I | 20160630 | 20160715 | 20160715 | EXP | NL-WEST-WARD PHARMACEUTICALS CORP.-NL-H14001-16-01301 | WESTWARD | VAN AALST J,TEERNSTRA O,WEBER W,RIJKERS K. AN UNUSUAL CASE OF POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME IN A PATIENT BEING WEANED FROM INTRATHECAL MORPHINE. INTERNATIONAL MEDICAL CASE REPORTS JOURNAL 2016;9:117-120. | 63.00 | YR | F | Y | 0.00000 | 20160715 | MD | NL | NL |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125620411 | 12562041 | 1 | PS | CO-AMOXICLAV | AMOXICILLINCLAVULANIC ACID | 1 | Unknown | 65191 | |||||||||||
125620411 | 12562041 | 2 | SS | CO-AMOXICLAV | AMOXICILLINCLAVULANIC ACID | 1 | Intravenous (not otherwise specified) | 65191 | 200 | MG | QID | ||||||||
125620411 | 12562041 | 3 | SS | DIAZEPAM APOTEX, TABLETTEN | DIAZEPAM | 1 | Oral | 0 | 5 | MG | TID | ||||||||
125620411 | 12562041 | 4 | SS | AMITRIPTYLINE HCL APOTEX TABLETTEN | AMITRIPTYLINE | 1 | Unknown | 0 | |||||||||||
125620411 | 12562041 | 5 | SS | AMITRIPTYLINE HCL APOTEX TABLETTEN | AMITRIPTYLINE | 1 | Unknown | 0 | |||||||||||
125620411 | 12562041 | 6 | SS | MORPHINE | MORPHINE | 1 | Intrathecal | 0 | |||||||||||
125620411 | 12562041 | 7 | SS | MORPHINE | MORPHINE | 1 | Intrathecal | 0 | .5 | MG | |||||||||
125620411 | 12562041 | 8 | SS | MORPHINE | MORPHINE | 1 | Intrathecal | 0 | .5 | MG | |||||||||
125620411 | 12562041 | 9 | SS | CLINDAMYCIN | CLINDAMYCINCLINDAMYCIN PHOSPHATE | 1 | Unknown | 0 | 300 | MG | QID | ||||||||
125620411 | 12562041 | 10 | SS | CLONIDINE. | CLONIDINE | 1 | Oral | 0 | .15 | MG | TID | ||||||||
125620411 | 12562041 | 11 | SS | OXYCONTIN | OXYCODONE HYDROCHLORIDE | 1 | Oral | 0 | 20 | MG | QID | ||||||||
125620411 | 12562041 | 12 | SS | DUROGESIC | FENTANYL | 1 | Transdermal | 0 | 100 | UG | |||||||||
125620411 | 12562041 | 13 | SS | SEVOFLURANE. | SEVOFLURANE | 1 | Unknown | 0 | |||||||||||
125620411 | 12562041 | 14 | SS | PROPOFOL. | PROPOFOL | 1 | Unknown | 0 | |||||||||||
125620411 | 12562041 | 15 | SS | SUFENTANIL | SUFENTANIL | 1 | Unknown | 0 | |||||||||||
125620411 | 12562041 | 16 | SS | ROCURONIUM | ROCURONIUM BROMIDE | 1 | Unknown | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125620411 | 12562041 | 1 | Product used for unknown indication |
125620411 | 12562041 | 3 | Muscle spasms |
125620411 | 12562041 | 4 | Amputation stump pain |
125620411 | 12562041 | 6 | Amputation stump pain |
125620411 | 12562041 | 9 | Product used for unknown indication |
125620411 | 12562041 | 10 | Analgesic therapy |
125620411 | 12562041 | 11 | Analgesic therapy |
125620411 | 12562041 | 12 | Analgesic therapy |
125620411 | 12562041 | 13 | General anaesthesia |
125620411 | 12562041 | 14 | General anaesthesia |
125620411 | 12562041 | 15 | General anaesthesia |
125620411 | 12562041 | 16 | General anaesthesia |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125620411 | 12562041 | HO |
125620411 | 12562041 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125620411 | 12562041 | Hemiparesis | |
125620411 | 12562041 | Off label use | |
125620411 | 12562041 | Posterior reversible encephalopathy syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |